“Smoking Memo – or Bad Journalism” – that’s the title of Maggie Mahar’s blog post on the alleged Obama-PhRMA deal. Excerpt:
Yesterday, it seemed that the Huffington Post’s Ryan Grim had a scoop. He reported that Huffington has obtained a memo that “confirms” that the White House and the pharmaceutical lobby secretly made a deal–the deal that I wrote about a few days ago in a post titled “What Was Billy Tauzin Thinking?” According to the memo, the White House supposedly pledged to oppose any Congressional efforts to let Medicare negotiate for discounts on drugs, or to import drugs from Canada.
The memo in question turns out to be typed–and unsigned. How does the reporter know that it is authentic? “A knowledgeable health care lobbyist” told him so. According to the lobbyist the memo “was prepared by a person directly involved in the negotiations [and it] lists exactly what the White House gave up, and what it got in return.
Wait a minute. As PhRMA senior vice president Ken Johnson points out later in the story: “Anyone could have written it. Unless it comes from our board of directors, it’s not worth the paper it’s written on. . . .”
And who is the “knowledgeable lobbyist” who gave the memo to Huffington? His name is not disclosed.
What we have then, is a story based on what one unnamed source says–and a typed memo that probably is untraceable.
She goes on to quote me about whether this is acceptable journalism.
Opinions on other issues in news, journals, PR, advertising, marketing
Monday at #ADA2021, an infectious disease epidemiologist, a journalist, and a researcher shared perspectives on communication of risk in the era of COVID-19: http://ow.ly/ROfR30rMeE7 @AstleyCM @garyschwitzer @berthahidalgo @ADA_DiabetesPro
Shoutouts to @susan_bewley @drkevinknopf @MichaelBaum11 in this call for more than fawning coverage from press releases for these kinds of stories.
Also, linked history inside goes back 5 years just on Grail apparently trying to become Holy Grail. https://twitter.com/garyschwitzer/status/1408849696416841731
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like